Alzheimer's Diagnosis & Assessment in Cuba

The Cuban Diagnostic Approach

Cuba's approach to Alzheimer's diagnosis is comprehensive and multidisciplinary. Rather than relying on a single test, Cuban neuroscience centers assemble a team of neurologists, neuropsychologists, psychiatrists, and rehabilitation specialists to evaluate each patient from multiple clinical angles.

This team-based model, practiced at institutions like CIREN (International Center for Neurological Restoration) in Havana, ensures that cognitive symptoms are assessed in the context of the patient's full medical history, neurological status, imaging findings, and psychosocial factors — leading to more accurate diagnoses and personalized treatment plans.

Components of the Diagnostic Evaluation

A full Alzheimer's diagnostic assessment in Cuba typically includes:

• Medical history and family history review — documenting symptoms, onset, progression, medications, and risk factors. • Neurological examination — assessing reflexes, coordination, muscle tone, and sensory function to rule out other neurological conditions. • Neuropsychological testing — a battery of standardized tests measuring memory, language, attention, executive function, and visuospatial skills. This provides objective cognitive scores and identifies specific deficit patterns. • Brain MRI (Magnetic Resonance Imaging) — visualizing brain structure to detect atrophy (particularly in the hippocampus), rule out tumors or strokes, and assess vascular health. • Laboratory blood tests — excluding reversible causes of cognitive decline such as thyroid dysfunction, vitamin B12 deficiency, infections, or metabolic imbalances. • Functional assessment — evaluating how cognitive changes affect daily living activities and independence. • Psychiatric evaluation — screening for depression, anxiety, or other conditions that can mimic or accompany Alzheimer's.

Staging Alzheimer's Disease

Following the evaluation, Cuban neurologists classify the stage of cognitive impairment:

• Mild Cognitive Impairment (MCI) — noticeable cognitive changes that don't significantly interfere with daily function. MCI may or may not progress to Alzheimer's. • Mild Alzheimer's disease — memory and cognitive problems are evident and begin to affect daily activities, but the patient retains independence in most tasks. • Moderate Alzheimer's — cognitive decline is significant; the patient needs increasing assistance with daily activities and may experience behavioral changes. • Severe Alzheimer's — profound cognitive impairment; the patient requires full-time care and loses the ability to communicate effectively.

Cuba's treatment programs are most effective at the MCI and mild-to-moderate stages, where neuroprotective therapy and intensive cognitive rehabilitation can help preserve remaining cognitive function.

What International Patients Should Bring

International patients traveling to Cuba for an Alzheimer's evaluation should bring:

• All previous medical records, imaging (MRI/CT on CD), and laboratory results • List of current medications and dosages • Family member or caregiver who can provide observations about symptom progression • Passport and travel documents • Any prior neuropsychological test results

The diagnostic evaluation typically requires 3-5 days. Following assessment, the multidisciplinary team meets to discuss findings and recommends a personalized treatment plan, which may include a 4-week intensive rehabilitation program or an outpatient neuroprotective protocol.